Aterian, Inc. (NASDAQ:ATER) Short Interest Update

Aterian, Inc. (NASDAQ:ATERGet Free Report) was the recipient of a large growth in short interest during the month of February. As of February 15th, there was short interest totalling 251,300 shares, a growth of 25.4% from the January 31st total of 200,400 shares. Approximately 3.6% of the shares of the company are short sold. Based on an average daily volume of 64,600 shares, the days-to-cover ratio is currently 3.9 days.

Aterian Trading Up 3.5 %

NASDAQ:ATER opened at $2.08 on Wednesday. The company has a market capitalization of $18.21 million, a P/E ratio of -0.76 and a beta of 2.03. Aterian has a 12 month low of $1.86 and a 12 month high of $6.54. The firm has a fifty day simple moving average of $2.25 and a 200-day simple moving average of $2.62.

Institutional Trading of Aterian

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Renaissance Technologies LLC increased its holdings in shares of Aterian by 93.3% in the fourth quarter. Renaissance Technologies LLC now owns 45,493 shares of the company’s stock valued at $109,000 after purchasing an additional 21,958 shares during the period. Squarepoint Ops LLC purchased a new stake in Aterian in the fourth quarter valued at approximately $64,000. Finally, Jane Street Group LLC acquired a new position in Aterian in the 3rd quarter worth approximately $33,000. Institutional investors and hedge funds own 7.02% of the company’s stock.

About Aterian

(Get Free Report)

Aterian, Inc, together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. Its platform offers home and kitchen appliances; kitchenware; cooling and air quality appliances, such as dehumidifiers; health and beauty products; and essential oils under the Squatty Potty, hOmeLabs, Mueller, Pursteam, Healing Solutions, and Photo Paper Direct brand names.

Featured Articles

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.